Skip to main content

Advertisement

Log in

Duration of prophylaxis with trimethoprim–sulfamethoxazole in patients undergoing solid organ transplantation

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601–14.

    Article  PubMed  CAS  Google Scholar 

  2. Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis. 2001;33:1397–405.

    Article  PubMed  CAS  Google Scholar 

  3. Martin SI, Fishman JA; AST Infectious Diseases Community of Practice. Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant. 2009;9:S227–33.

    Article  PubMed  Google Scholar 

  4. Orr KE, Gould FK, Short G, et al. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect. 1994;29:249–53.

    Article  PubMed  CAS  Google Scholar 

  5. Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation. 2009;88:135–41.

    Article  PubMed  Google Scholar 

  6. Di Cocco P, Orlando G, Bonanni L, et al. A systematic review of two different trimetoprim–sulfamethoxazole regimens used to prevent Pneumocystis jirovecii and no prophylaxis at all in transplant recipients: appraising the evidence. Transplant Proc. 2009;41:1201–3.

    Article  PubMed  Google Scholar 

  7. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, editors. Clinical approach to infection in the compromised host. 3rd ed. New York: Plenum Publishing; 1994. p. 629–705.

    Chapter  Google Scholar 

  8. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim–sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim–sulfamethoxazole, effects on the microflora, and the cost–benefit of prophylaxis. Am J Med. 1990;89:255–74.

    Article  PubMed  CAS  Google Scholar 

  9. Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation. 2009;88:380–5.

    Article  PubMed  Google Scholar 

  10. Arend SM, Westendorp RG, Kroon FP, et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis. 1996;22:920–5.

    Article  PubMed  CAS  Google Scholar 

  11. De Castro N, Xu F, Porcher R, Pavie J, Molina JM, Peraldi MN. Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study. Clin Microbiol Infect. 2010;16:1375–7.

    Article  PubMed  Google Scholar 

  12. Derouin F, Pelloux H; ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–101.

    Article  PubMed  CAS  Google Scholar 

  13. Martina MN, Cervera C, Esforzado N, et al. Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review. Transpl Int. 2011;24:e6–12.

    Article  PubMed  Google Scholar 

  14. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21:1387–94.

    Article  PubMed  CAS  Google Scholar 

  15. Schwartz JJ, Ishitani MB, Weckwerth J, Morgenstern B, Milliner D, Stegall MD. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation. 2007;84:715–21.

    Article  PubMed  CAS  Google Scholar 

  16. Schooley RT, Hirsch MS, Colvin RB, et al. Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med. 1983;308:307–13.

    Article  PubMed  CAS  Google Scholar 

  17. Cheeseman SH, Henle W, Rubin RH, et al. Epstein–Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med. 1980;93:39–42.

    PubMed  CAS  Google Scholar 

  18. Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48:772–86.

    Article  PubMed  CAS  Google Scholar 

  19. Louis S, Audrain M, Cantarovich D, et al. Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids. Transplantation. 2007;83:712–21.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Malhotra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malhotra, P., Rai, S.D. & Hirschwerk, D. Duration of prophylaxis with trimethoprim–sulfamethoxazole in patients undergoing solid organ transplantation. Infection 40, 473–475 (2012). https://doi.org/10.1007/s15010-012-0277-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-012-0277-y

Keywords

Navigation